Use of secretory products of human lacrimal gland acinar epithelia for tear replacement therapy

摘要

The present invention relates to medicinal compositions and more particularly refers to such compositions for tear replacement therapy having products of human lacrimal gland acinar epithelia, and more specifically, growth factors or cytokines, in particular, the transforming growth factor beta (TGF).